CD8+ TILs exhibited enhanced Peroxisome proliferator-activated receptor alpha (PPAR-α) signaling and fatty acid catabolism in both mouse models and melanoma patients, which is critical for their ability to suppress tumor growth [83]. Here, CD8A is linked to melanoma.